Is obesity an independent risk factor for cardiovascular disease?

Researchers explore how obesity contributes to cardiovascular disease by investigating this association in low-risk people.

Non-infectious Uveitis drugs in development, 2024

GlobalData tracks 19 drugs in development for Non-infectious Uveitis by 20 companies/universities/institutes. The top development phase for Non-infectious Uveitis is preclinical, with seven drugs in

August 31, 2024

Comparing the lasting effects: post COVID vs. non-COVID acute respiratory infections

Symptom profiles between individuals with prior COVID-19 and those with other acute respiratory infections (ARIs).

October 10, 2023

Supreme Court’s gutting of Chevron doctrine could mean headaches for drug industry

The Food and Drug Administration’s power to make important regulatory decisions is in question after a Supreme Court decision weakening agencies’ ability to interpret ambiguous

June 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.